5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine - CAS 875781-18-3

Catalog:	BB038531
Product Name:	5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine
CAS:	875781-18-3
Synonyms:	5-bromo-3-iodo-2H-pyrazolo[3,4-b]pyridine

Technical Data

Safety and Hazards

Patents

Computed Properties

IUPAC Name:	5-bromo-3-iodo-2H-pyrazolo[3,4-b]pyridine
Description:	5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine (CAS# 875781-18-3) is a useful research chemical.
Molecular Weight:	323.92
Molecular Formula:	C6H3BrIN3
Canonical SMILES:	C1=C(C=NC2=NNC(=C21)I)Br
InChI:	InChI=1S/C6H3BrIN3/c7-3-1-4-5(8)10-11-6(4)9-2-3/h1-2H,(H,9,10,11)
InChI Key:	ZBPXFBHBTCYAQS-UHFFFAOYSA-N
Boiling Point:	409.1 °C at 760 mmHg
Purity:	97.0 %
Density:	2.559 g/cm³
MDL:	MFCD09878697
LogP:	2.32500

Publication Number	Title	Priority Date
WO-2021018820-A1	Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death	20190729
US-2019298729-A1	Imidazopiperazine inhibitors of transcription activating proteins	20180329
WO-2019191667-A1	Imidazopiperazine inhibitors of transcription activating proteins	20180329
AU-2019245403-A1	Imidazopiperazine inhibitors of transcription activating proteins	20180329
BR-112020019824-A2	STRUCTURAL FORMULA I COMPOUND OR A SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, CBP INHIBITION METHOD, P300 INHIBITION METHOD, METHOD OF TREATING A DISEASE MEASURED BY A CBE, METHOD OF TREATING A MEDIATED ILLNESS EFFECT ON A PATIENT	20180329

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Azaindoles

[885500-55-0]
Ethyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate
[757978-18-0]
5-Bromo-3-iodo-7-azaindole
[850892-97-6]
tert-butyl 4-bromo-1H-pyrrolo[2,3-c]pyridine-1-carboxylate
[23688-47-3]
3-Bromo-4-azaindole
[1215387-58-8]
5-Bromo-6-azaindole
[192189-18-7]
1-Boc-3-iodo-7-azaindole

Pyridines

[1006443-01-1]
1-(5-Nitropyridin-2-yl)-1H-pyrazole-3-carboxylic acid
[104496-91-5]
2-(Pyridin-2-ylthio)acetohydrazide
[202288-73-1]
2-(Pyridin-3-ylmethoxy)aniline dihydrochloride
[76167-49-2]
2-(Pyridin-3-yloxy)aniline
[942206-23-7]
2,5-Dichloro-3-iodopyridine
[856848-33-4]
2-Amino-4,5-dibromopyridine

GHS Hazard Statement:	H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement:	P264, P270, P301+P312, P330, and P501
Signal Word:	Warning

Complexity:	157
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	322.85551
Formal Charge:	0
Heavy Atom Count:	11
Hydrogen Bond Acceptor Count:	2
Hydrogen Bond Donor Count:	1
Isotope Atom Count:	0
Monoisotopic Mass:	322.85551
Rotatable Bond Count:	0
Topological Polar Surface Area:	41.6 Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	2.2